WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹500 Cr | ₹511 Cr | ₹393 Cr | ₹367 Cr | ₹391 Cr |
What is the latest Revenue of WANBURY ?
Year | Revenue |
---|---|
Mar2024 | ₹500 Cr |
Mar2023 | ₹511 Cr |
Mar2022 | ₹393 Cr |
Mar2021 | ₹367 Cr |
Mar2020 | ₹391 Cr |
How is Revenue of WANBURY Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹500 Cr | -2.26 | |
Mar2023 | ₹511 Cr | 30.23 | |
Mar2022 | ₹393 Cr | 6.82 | |
Mar2021 | ₹367 Cr | -6.11 | |
Mar2020 | ₹391 Cr | - |
Compare Revenue of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹895.2 Cr | 8.2% | -1.2% | 30.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 8.2% |
-1.2% |
30.4% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses